Cetuximab

Cetuximab is a type of medicine used in cancer treatment, specifically for certain head and neck cancers and colorectal cancers. It is a monoclonal antibody, which means it is designed to target and block a protein called EGFR (epidermal growth factor receptor) that helps cancer cells grow. By interfering with this protein, cetuximab can slow or stop the growth of tumors. It is typically given through an intravenous infusion and can be used alone or alongside other treatments, such as chemotherapy. Doctors carefully choose patients for cetuximab based on their specific cancer characteristics.